ArticleFrontiers in pharmacology2022

Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy.

Ping Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.